Dr. Setia is a surgical pathologist with a subspecialty focus in gastrointestinal pathology.
Massachusetts General Hospital/Harvard Medical School
Fellowship - Gastrointestional Pathology
2014
Baystate Medical Center/Tufts University School of Medicine
Fellowship - Cytopathology
2013
Brigham and Women's Hospital/Harvard Medical School
Boston
Fellowship - Surigal Pathology
2012
Baystate Medical Center/Tufts University School of Medicine
MD
2008
Maulana Azad Medical College
New Delhi, India
MD
2004
Lady Hardings Medical College
New Delhi, India
MBBS
1997
Collagenous gastritis: clinical features, histologic correlates and unanswered questions.
Collagenous gastritis: clinical features, histologic correlates and unanswered questions. Histopathology. 2025 Dec; 87(6):789-801.
PMID: 40911031
Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement.
Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer. 2025 Jul 01; 131(13):e35874.
PMID: 40558065
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement.
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Ann Surg Oncol. 2025 Jun 25.
PMID: 40560501
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes.
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes. Virchows Arch. 2025 Dec; 487(6):1213-1222.
PMID: 40358740
High risk features in colorectal adenomatous polyps: A multi-institutional study.
High risk features in colorectal adenomatous polyps: A multi-institutional study. Ann Diagn Pathol. 2024 Oct; 72:152323.
PMID: 38733674
A novel telomere biology disease-associated gastritis identified through a whole exome sequencing-driven approach.
A novel telomere biology disease-associated gastritis identified through a whole exome sequencing-driven approach. J Pathol Clin Res. 2024 01; 10(1):e349.
PMID: 37994393
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48.
PMID: 28978556